Patients with end-stage kidney disease (ESKD) who require dialysis often find themselves caught in what feels like an endless cycle of long dialysis sessions followed by lengthy recovery periods. Traditional dialysis, which requires travel to a dialysis clinic three times per week for treatment, has a high impact on quality of life for these patients.
In contrast, onsite dialysis, performed at the skilled nursing facility (SNF) where a patient resides, allows for more frequent, shorter dialysis sessions (pursuant to a physician’s order). These patients no longer have to endure lengthy transportation to and from their treatments, and even better, have a faster recovery allowing them to focus on rehabilitation or other activities between sessions.
Residents of skilled nursing facilities who also need dialysis are often older, frail, and have multiple comorbidities. Alongside dialysis, they typically have rehabilitation activities scheduled. Traditional dialysis can take up to six hours or more to complete (including transportation to/from a dialysis center). Plus, with up to 21 hours of post-treatment recovery time, it is easy to see how a Monday-Wednesday-Friday routine could interfere with rehabilitation and daily life for these patients.
Consider the example of Gladys, a 72-year-old SNF resident who was discharged to the SNF from the hospital after a fall. Gladys needs physical therapy due to a hip injury sustained in her fall, and dialysis due to her ESKD. She also has a history of congestive heart failure. This is a typical day for Gladys, who is scheduled for traditional dialysis at an off-site treatment center:
Dialyze Direct partners with SNF facilities to offer onsite, patient-centric dialysis in treatment “dens” to patients that exhibit co-morbidities that are deemed medically reasonable and necessary to receive more frequent dialysis (MFD). Their overall plan of care is supported and supervised by a team of experts including specially trained nurses.
John, a 75-year-old grandfather of five, has recently been transferred to a SNF following a hospital stay due to pneumonia. He’s deconditioned from his illness, requires rehabilitation services, and has a history of ESKD. A typical day for him is as follows:
As illustrated by these patient stories, there is a significant difference in outcomes between traditional dialysis and MFD. Research has shown that traditional dialysis commonly results in hospital admissions on the day of treatment and that rates of sudden cardiac death following this type of dialysis are highest on Mondays.
In contrast, MFD is gentler, resulting in fewer complications. In fact, Dialyze Direct has seen 65% fewer dialysis-related hospitalizations and a 94% reduction in vascular infections in patients receiving this model of care. In addition, MFD results in faster post-treatment recovery times. 92% of patients report recovery to baseline within 2 hours of treatment. Lastly, onsite SNF dialysis significantly reduces patient risk of infection, including COVID-19, by eliminating exposure at the offsite dialysis center.
Alongside these benefits to SNF patients with ESKD, there is a benefit for other key stakeholders as well. Transportation costs are reduced by 100% since patients do not need to leave the SNF for dialysis, and better patient outcomes drive high success rates with complex ESKD patients, a benefit for SNFs participating in patient-driven payment models (PDPM).
This patient population is projected to grow; currently, the rate of increase for ESKD is roughly 21,000 additional patients each year in the U.S., with Medicare devoting $80 billion a year to treating patients with chronic kidney disease.
For all reasons outlined above, MFD holds significant potential as a driver of cost-effective, improved long-term outcomes for patients. These include fewer complications, lower hospitalization rates, increased access to rehabilitation services, and quality-of-life enhancements. Because these positive results have potential to extend beyond the SNF, they merit continued investment in this modality of care.
For more information on the Dialyze Direct difference and SNF onsite more frequent dialysis (MFD), email firstname.lastname@example.org, visit www.dialyzedirect.com, or call 855-934-2569.
Alice Hellebrand, DNP, RN, CNN has been with Dialyze Direct since its inception in 2015 and is responsible for overseeing the design and implementation of patient care delivery, clinical staff education, and clinical quality improvement. She has authored many journal publications and her expertise has been sought as a presenter nationally and internationally at nephrology, dialysis, and skilled nursing conferences. Her continued dedication to the Dialyze Direct model of dialysis care gives her unique insights into this pioneering approach to treatment.